A deadly form of leukemia may be stopped before it ever develops by introducing targeted maternal screening in the United ...
The FDA and EMA have set out updated regulatory agendas that will shape biologics manufacturing standards in coming years. The FDA’s Center for Biologics Evaluation and Research (CBER) 2026 agenda ...
Researchers at Kumamoto University have uncovered a previously unknown molecular mechanism by which human T-cell leukemia virus type I (HTLV-1) drives the development of adult T-cell leukemia-lymphoma ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results